Article

Vitamin maker launches new Web site

Vitamin maker ZeaVision LLC has launched a new Web site designed to educate consumers about nutrition and eye health.

St. Louis-Vitamin maker ZeaVision LLC has launched a new Web site designed to educate consumers about nutrition and eye health.

“Eye health is often ignored unless there is a problem, so many people are unaware that they can proactively help preserve healthy vision and fight vision loss, including nutrition and supplementation,” said Terry Sullivan, vice president of sales and marketing at ZeaVision. “We designed the new [site] to serve as a comprehensive resource for anyone who is interested in learning more about eye health, nutrition, and maximizing visual performance.”

The site, www.eyepromise.com, includes videos, patient testimonials, and doctor-provided content; blogs and online discussions; and information about signing up for a newsletter and enrolling in a free referral program.

The site also features promotions such as a game wherein players learn about dry eye causes and symptoms and have the chance to win prizes. Another promotion is a buy one, get one free offer on the company’s omega-3‒based supplement for dry eye (EyePromise EZ Tears), including a 60-day money back guarantee.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.